SEARCH OUR PRODUCT CATALOG

ACTG2-ALK Fusion FISH Probe

The ACTG2-ALK Fusion FISH Probe is used to confirm a fusion of the ACTG2 and ALK genes. The fusion of the ACTG2 and ALK genes has been associated with Sarcoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.

** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.

Turnaround Time: 7-10 Business Days    Shipping Time: 1-2 Day Expedited Shipping

SKU Test Kits Buffer Dye Color Order Now
ACTG2-ALK-20-ORGR  (Standard Design) 20 (40 μL) 200 μL
ACTG2-ALK-20-RERE 20 (40 μL) 200 μL
ACTG2-ALK-20-REOR 20 (40 μL) 200 μL
ACTG2-ALK-20-REGO 20 (40 μL) 200 μL
ACTG2-ALK-20-REGR 20 (40 μL) 200 μL
ACTG2-ALK-20-REAQ 20 (40 μL) 200 μL
ACTG2-ALK-20-ORRE 20 (40 μL) 200 μL
ACTG2-ALK-20-OROR 20 (40 μL) 200 μL
ACTG2-ALK-20-ORGO 20 (40 μL) 200 μL
ACTG2-ALK-20-ORAQ 20 (40 μL) 200 μL
ACTG2-ALK-20-GORE 20 (40 μL) 200 μL
ACTG2-ALK-20-GOOR 20 (40 μL) 200 μL
ACTG2-ALK-20-GOGO 20 (40 μL) 200 μL
ACTG2-ALK-20-GOGR 20 (40 μL) 200 μL
ACTG2-ALK-20-GOAQ 20 (40 μL) 200 μL
ACTG2-ALK-20-GRRE 20 (40 μL) 200 μL
ACTG2-ALK-20-GROR 20 (40 μL) 200 μL
ACTG2-ALK-20-GRGO 20 (40 μL) 200 μL
ACTG2-ALK-20-GRGR 20 (40 μL) 200 μL
ACTG2-ALK-20-GRAQ 20 (40 μL) 200 μL
ACTG2-ALK-20-AQRE 20 (40 μL) 200 μL
ACTG2-ALK-20-AQOR 20 (40 μL) 200 μL
ACTG2-ALK-20-AQGO 20 (40 μL) 200 μL
ACTG2-ALK-20-AQGR 20 (40 μL) 200 μL
ACTG2-ALK-20-AQAQ 20 (40 μL) 200 μL

ACTG2 Gene Summary

Actins are highly conserved proteins that are involved in various types of cell motility and in the maintenance of the cytoskeleton. Three types of actins, alpha, beta and gamma, have been identified in vertebrates. Alpha actins are found in muscle tissues and are a major constituent of the contractile apparatus. The beta and gamma actins co-exist in most cell types as components of the cytoskeleton and as mediators of internal cell motility. This gene encodes actin gamma 2; a smooth muscle actin found in enteric tissues. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Based on similarity to peptide cleavage of related actins, the mature protein of this gene is formed by removal of two N-terminal peptides.[provided by RefSeq, Dec 2010]

Gene Name: Actin, Gamma 2, Smooth Muscle, Enteric

Chromosome: CHR2: 74120092 -74146780

Locus: 2p13.1

ALK Gene Summary

This gene encodes a receptor tyrosine kinase, which belongs to the insulin receptor superfamily. This protein comprises an extracellular domain, an hydrophobic stretch corresponding to a single pass transmembrane region, and an intracellular kinase domain. It plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. This gene has been found to be rearranged, mutated, or amplified in a series of tumours including anaplastic large cell lymphomas, neuroblastoma, and non-small cell lung cancer. The chromosomal rearrangements are the most common genetic alterations in this gene, which result in creation of multiple fusion genes in tumourigenesis, including ALK (chromosome 2)/EML4 (chromosome 2), ALK/RANBP2 (chromosome 2), ALK/ATIC (chromosome 2), ALK/TFG (chromosome 3), ALK/NPM1 (chromosome 5), ALK/SQSTM1 (chromosome 5), ALK/KIF5B (chromosome 10), ALK/CLTC (chromosome 17), ALK/TPM4 (chromosome 19), and ALK/MSN (chromosome X).[provided by RefSeq, Jan 2011]

Gene Name: ALK Receptor Tyrosine Kinase

Chromosome: CHR2: 29415639 -30144477

Locus: 2p23.2-p23.1

Gene Diseases

The ACTG2 ALK Fusion has been associated with the following diseases:

Disease Name
Sarcoma

FISH Probe Protocols

Protocol, Procedure, or Form Name Last Modified Download

Atypical Spitzoid Neoplasms in Childhood: A Molecular and Outcome Study

Atypical spitzoid neoplasms (APNs) are primarily pediatric lesions characterized by their intermediate features; clinically and histopathologically, they fall somewhere between benign spitz nevi and malignant melanoma. The genetics of these tumors are still poorly understood. In this study, 34 APNs were analyzed using FISH and IHC. Our ALK, BRAF, and NTRK1 break-apart FISH probes were used to detect rearrangements of the genes .

Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas

While studies are plentiful on adult gliomas, infant cases are historically understudied. This team sought to account for that lack of data by analyzing glioma biopsies from 150 infants. As part of genetic profiling, our ALK break apart probe was used to detect ALK rearrangements. The team was able to divide the tumors into three genetic subtypes that were tightly tied to clinical outcome. They also found that many of the tumors harbored just a single oncogene, evidence that infant gliomas are usually single driver tumors.

ALK-rearranged renal cell carcinomas in Polish population

Since the first report 2010, 22 cases of ALK-rearranged renal cell carcinoma (RCC) have been described. This study screened over 1000 Polish RCC patients for ALK translocations using IHC followed by FISH with our ALK break apart FISH probe. Only 31 cases were considered potentially positive or indeterminable by IHC; of these, none tested positive for ALK rearrangement with FISH. These results suggests that the mutation might be related to ethnicity, warranting further investigation into its prevalence in other ethnicities.